Ocumetics Director and CEO, Dean Burns, covers key details of our upcoming first-in-human study and recently opened private placement financing. Topics will include:
- Final steps leading up to the first-in-human study
- Details on the now-open private placement investment opportunity
- Live Q&A session with Dean Burns
Thanks to everyone who joined us for the Webinar. It was an amazing turnout, and it was great to hear your questions and comments. We look forward to hosting more webinars in the future!
https://youtu.be/Ijzsqq2myh4
Tired of glasses? New lens technologies might offer a better way to see and experience the world. Anyone who relies on corrective eyewear has experienced its drawbacks. Maybe you are approaching your 50’s and need glasses to see up close. Maybe you left your reading glasses at home and find yourself asking for help deciphering
Ocumetics believes its accommodating lens technology could transform the eye care industry. Dr. Garth Webb, Ocumetics’ Founder and Chief Scientific Officer, thinks nothing is as beautiful as the lens in the human eye. “It’s this gorgeous, crystal-like orb that hides just behind the pupil,” he says. But it doesn’t stay that way forever. Inevitably, as
Many of the questions we receive from investors relate to the process for obtaining US Food and Drug Administration (FDA) approval for surgical devices, such as the Ocumetics Accommodating Lens. This month’s message is focused on outlining how the process works and unpacking the steps required to obtain FDA approval. You will be thrilled to
Imagine a world in which glasses and traditional contact lenses become obsolete, and natural vision is restored with a simple and innovative solution.
That's precisely what we aim to achieve with the Ocumetics Accommodating Lens technology (“Ocumetics Accommodating Lens”).
